Answering mRNA Skepticism: Platform History, Safety, and Alternatives

This episode, "Answering mRNA Skepticism: Platform History, Safety, and Alternatives," features the panel tackling specific objections patients raise about mRNA technology.

Dr. Jeff Goad asks how pharmacists can tailor vaccine conversations for patients with different specific objections, distinguishing those worried about side effects from those simply uneasy about newer mRNA technology. Dr. Marcel Curlin responds that patient concerns vary widely and require different responses.

For patients wary of mRNA specifically, Curlin offers important context. mRNA vaccine platforms are not new technology invented for COVID-19, he explains. They existed in development for more than fifteen years before the pandemic began. The global urgency of COVID-19 simply accelerated their deployment, he says, bringing a platform that was already being researched into widespread use more quickly than originally planned. Curlin also highlights a key advantage of the mRNA approach: it can be adapted rapidly to target new viral strains without changing the underlying delivery platform.

Curlin then addresses a common misconception. Some patients worry that mRNA could persist or alter their genetic material, he says, but the RNA itself degrades quickly and never becomes DNA. The original vaccine material is completely metabolized and gone from the body, he emphasizes. For patients who remain unpersuaded, or who found a previous mRNA dose left them feeling unwell, Curlin recommends the protein-based alternative. He shares a personal example: his own son switched to the protein-based vaccine and described the experience as a breeze, with no noticeable side effects.

Dr. Goad then raises a practical question about mixing platforms across different years. Curlin confirms that early pandemic-era studies showed no problem with switching between vaccine types from one season to the next. It genuinely does not matter which platform a patient received previously, he says. The consistent message, both physicians agree, is simply to get vaccinated using whichever available platform best fits the patient's preferences and history.

Our next episode, "COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted," examines how vaccine hesitancy itself has changed since the height of the pandemic.